Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)-Reference-Cited by-同舟云学术

Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)

Published:2015-12-04 Issue:24 Volume:58 Page:9480-9497
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Zhou Han-Jie¹,Wang Jinhai¹,Yao Bing¹,Wong Steve¹,Djakovic Stevan¹,Kumar Brajesh¹,Rice Julie¹,Valle Eduardo¹,Soriano Ferdie¹,Menon Mary-Kamala¹,Madriaga Antonett¹,Kiss von Soly Szerenke¹,Kumar Abhinav¹,Parlati Francesco¹,Yakes F. Michael¹,Shawver Laura¹,Le Moigne Ronan¹,Anderson Daniel J.¹,Rolfe Mark¹,Wustrow David¹

Affiliation:

1. Cleave Biosciences Inc., 866 Malcom Road, Burlingame, California 94010, United States

Funder

Cleave Biosciences, Inc.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b01346

Reference45 articles.

1. Use of a cDNA clone to identify a supposed precursor protein containing valosin